StreetInsider.com News Articles

H.C. Wainwright Reiterates Buy Rating on Rockwell Medical Technologies (RMTI)

Fri, 22 May 2026 06:58:35 -0400

H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $2.00 price target on Rockwell Medical Technologies (NASDAQ: RMTI).

The analyst commented: "Rockwell Medical recently reported favorable news on the long-term contract front with elements of its customer base. Firstly, the company announced that it had entered into a three-year product purchase agreement with Heritage Dialysis, a Michigan-based family-owned company comprising dialysis professionals that specialize in providing home dialysis in skilled nursing facilities, assisted living and senior living communities, and patients' homes. The agreement, which includes supply and purchasing commitments, will be in effect for an initial three-year term, with options

Rockwell Medical renews dialysis product supply deal with aQua

Wed, 20 May 2026 06:00:55 -0400

Rockwell Medical Inc. (NASDAQ: RMTI) renewed its product purchase agreement with aQua Dialysis, LLP, a dialysis service provider in Texas, according to a company statement.

The two-year agreement includes supply and purchasing commitments, with options for two additional one-year renewals. Under the terms, Rockwell Medical will continue supplying liquid and dry acid and bicarbonate hemodialysis concentrates and other dialysis-related products to aQua Dialysis.

The Michigan-based company develops, manufactures and distributes hemodialysis products to dialysis providers worldwide. aQua Dialysis operates in-center hemodialysis and home dialysis services in Texas.

"We are pleased to continue supporting aQua Dialysis through our renewed agreement that reflects the strength

Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis

Wed, 20 May 2026 06:00:00 -0400

WIXOM, Mich.--(BUSINESS WIRE)-- Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company has renewed and extended its product purchase agreement (the "Agreement") with aQua Dialysis, LLP, a leading independent provider of in-center hemodialysis and home dialysis services in Texas.

The Agreement, which includes supply and purchasing commitments, will be in effect for two years with options to renew for two additional one-year periods. Under the Agreement, Rockwell Medical will continue to supply aQua Dialysis with the Company's

Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis

Wed, 20 May 2026 06:00:00 -0400

Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis

Wed, 20 May 2026 06:00:00 -0400

Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis

Wed, 20 May 2026 06:00:00 -0400

Rockwell Medical signs three-year supply deal with Heritage Dialysis

Thu, 14 May 2026 06:00:21 -0400

Rockwell Medical Inc. (NASDAQ: RMTI) entered into a three-year product purchase agreement with Heritage Dialysis, a Michigan-based dialysis provider that specializes in home dialysis services in skilled nursing facilities, assisted living communities, and patients' homes.

The agreement includes supply and purchasing commitments and runs for an initial three-year term with options for three additional one-year renewal periods. Under the contract, Rockwell Medical will supply Heritage Dialysis with hemodialysis products including PureCart bicarbonate cartridges, RenalPure liquid acetic acid-based solutions, SteriLyte liquid bicarbonate, and other dialysis-related products.

"Heritage Dialysis has built a care model that demands flexibility and operational consistency," said Tim Chole, chief

Rockwell Medical signs three-year supply deal with Heritage Dialysis

Thu, 14 May 2026 06:00:21 -0400

"Heritage Dialysis has built a care model that demands flexibility and operational consistency," said Tim Chole, chief

Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis

Thu, 14 May 2026 06:00:00 -0400

WIXOM, Mich.--(BUSINESS WIRE)-- Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company entered into a three-year product purchase agreement (the "Agreement") with Heritage Dialysis, a Michigan-based family-owned company comprised of dialysis professionals that specialize in providing home dialysis in skilled nursing facilities, assisted living and senior living communities, and patients' homes.

The Agreement, which includes supply and purchasing commitments, will be in effect for an initial three-year term, with options to renew for

Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis

Thu, 14 May 2026 06:00:00 -0400

WIXOM, Mich.--(BUSINESS WIRE)-- Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company entered into a three-year product purchase agreement (the "Agreement") with Heritage Dialysis, a Michigan-based family-owned company comprised of dialysis professionals that specialize in providing home dialysis in skilled nursing facilities, assisted living and senior living communities, and patients' homes.

The Agreement, which includes supply and purchasing commitments, will be in effect for an initial three-year term, with options to renew for

Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis

Thu, 14 May 2026 06:00:00 -0400

WIXOM, Mich.--(BUSINESS WIRE)-- Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company entered into a three-year product purchase agreement (the "Agreement") with Heritage Dialysis, a Michigan-based family-owned company comprised of dialysis professionals that specialize in providing home dialysis in skilled nursing facilities, assisted living and senior living communities, and patients' homes.

The Agreement, which includes supply and purchasing commitments, will be in effect for an initial three-year term, with options to renew for

Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis

Thu, 14 May 2026 06:00:00 -0400

WIXOM, Mich.--(BUSINESS WIRE)-- Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company entered into a three-year product purchase agreement (the "Agreement") with Heritage Dialysis, a Michigan-based family-owned company comprised of dialysis professionals that specialize in providing home dialysis in skilled nursing facilities, assisted living and senior living communities, and patients' homes.

The Agreement, which includes supply and purchasing commitments, will be in effect for an initial three-year term, with options to renew for

Form DEFA14A ROCKWELL MEDICAL, INC.

Mon, 11 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260511/26469367.html

Form DEFA14A ROCKWELL MEDICAL, INC.

Mon, 11 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260511/26469367.html

Form 8-K ROCKWELL MEDICAL, INC. For: May 08

Fri, 08 May 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260508/26462253.html

Form 8-K ROCKWELL MEDICAL, INC. For: May 08

Fri, 08 May 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260508/26462253.html

Form 8-K ROCKWELL MEDICAL, INC. For: May 07

Thu, 07 May 2026 07:14:00 -0400

si-local-file:///var/storage/secattach/20260507/26448132.html

Form 8-K ROCKWELL MEDICAL, INC. For: May 07

Thu, 07 May 2026 07:14:00 -0400

si-local-file:///var/storage/secattach/20260507/26448132.html

Form 10-Q ROCKWELL MEDICAL, INC. For: Mar 31

Thu, 07 May 2026 06:59:00 -0400

si-local-file:///var/storage/secattach/20260507/26447744.html

Form 10-Q ROCKWELL MEDICAL, INC. For: Mar 31

Thu, 07 May 2026 06:59:00 -0400

si-local-file:///var/storage/secattach/20260507/26447744.html

Form 8-K ROCKWELL MEDICAL, INC. For: May 07

Thu, 07 May 2026 06:16:00 -0400

si-local-file:///var/storage/secattach/20260507/26447354.html

Form 8-K ROCKWELL MEDICAL, INC. For: May 07

Thu, 07 May 2026 06:16:00 -0400

si-local-file:///var/storage/secattach/20260507/26447354.html

Rockwell Medical (RMTI) Tops Q1 EPS by 2c, provides guidance

Thu, 07 May 2026 06:07:09 -0400

Rockwell Medical (NASDAQ: RMTI) reported Q1 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $17.3 million versus the consensus estimate of $17.95 million.

GUIDANCE:

Rockwell Medical sees FY2026 revenue of $70-75 million, versus the consensus of $73.769 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.

Rockwell Medical (RMTI) Tops Q1 EPS by 2c, provides guidance

Thu, 07 May 2026 06:07:09 -0400

GUIDANCE:

Rockwell Medical sees FY2026 revenue of $70-75 million, versus the consensus of $73.769 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.

Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability

Thu, 07 May 2026 06:00:00 -0400

Reports $17.3 million in net sales, $2.9 million in gross profit, and 17% gross margin in the first quarter 2026.
Announces operational changes that are expected to generate more than $3 million in additional gross profit on an annualized basis.
2026 guidance reflects the Company's emphasis on growth, improved gross margin, and generating positive cash flow.

This